The Role of BTKi’s in the Management of CLL

Join us on Tuesday, January 10th at 2:00 pm ET for a candid conversation with panelists from AMCP’s Market Insights Roundtable on The Role of BTKi’s in the Management of CLL.  Speakers will provide an overview of the current and evolving coverage and treatment landscapes for managing CLL.

Speakers will share insights from the roundtable discussion which included current approaches to the treatment of CLL< the clinical information regarding the BTKi class and current and future approaches to the development of protocols and treatment pathways.  As more treatment options are available for CLL, payers discussed approaches to management and partnering with their provider network.  

The program will be facilitated by participants of the program:

Ryan Haumschild Pharm D, MS, MBA
Director of Pharmacy Services
Emory Healthcare and Winship Cancer Institute

Bhavesh Shah
Chief Pharmacy Officer Specialty and Hematology Oncology Pharmacy
Boston Medical Center (BMC)